Tell your friends about this item:
TRAIL Fas Ligand TNF and TLR3 in Cancer 1st ed. 2017 edition
TRAIL Fas Ligand TNF and TLR3 in Cancer
Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy.
317 pages, 35 Illustrations, color; 5 Illustrations, black and white; XIII, 317 p. 40 illus., 35 ill
| Media | Books Book |
| Released | July 10, 2017 |
| ISBN13 | 9783319568041 |
| Publishers | Springer International Publishing AG |
| Pages | 317 |
| Dimensions | 150 × 220 × 20 mm · 639 g |
| Language | German |
| Editor | Micheau, Olivier |